Our study also offers new insight into the biological significance conferred by miR-29s in the regulation of H3K9 methylation and provide a potential therapeutic approach in targetting TP53/miR-29s/SETDB1 regulatory circuitry for the treatment of NSCLC. This evidence concerns the gene SETDB1 and non-small cell lung carcinoma.